Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07595562 · ClinicalTrials.gov registry record
Acceptability of Soy Milk as a Calcium-Rich Beverage in School Children in New York City Public Schools
A clinical trial, sponsored by Physicians Committee for Responsible Medicine.
- Recruiting
- Registry status
- 2,500
- Enrollment target
NCT07595562: Recruiting study, sponsored by Physicians Committee for Responsible Medicine.
NCT07595562 is a clinical trial that is actively recruiting participants, run by Physicians Committee for Responsible Medicine. The registered enrollment target is 2,500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07595562 is actively recruiting participants, sponsored by Physicians Committee for Responsible Medicine.
- RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
Study Summary
NYC Public Schools is testing offering soy milk alongside dairy milk on the lunch line for all students during the month of May at select school sites to understand: * Whether students choose and drink soy milk * Whether offering soy milk can reduce milk waste * The potential environmental, nutrition, and cost impacts
Primary Outcome
Number of students who choose and drink soy milk or cow's milk. The quantity of soy milk and cow's milk consumed.
Interventions
- OTHER Acceptability of soy milk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2026-05-07 |
| Est. Completion | 2027-12 |
What NCT07595562 shows while recruiting
NCT07595562 is an observational study that tracks outcomes without assigning an intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Acceptability of soy milk is the first listed.
NCT07595562 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07595562 about?
NCT07595562 is a clinical study titled "Acceptability of Soy Milk as a Calcium-Rich Beverage in School Children in New York City Public Schools". NYC Public Schools is testing offering soy milk alongside dairy milk on the lunch line for all students during the month of May at select school sites to understand: * Whether students choose and drink soy milk * Whether offering soy milk can reduce milk waste * The potential environmental, nutriti...
What is the current status of trial NCT07595562?
This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2026-05-07. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07595562?
The interventions under investigation include: Acceptability of soy milk (OTHER).
Who is sponsoring clinical trial NCT07595562?
This trial is sponsored by Physicians Committee for Responsible Medicine, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI